NASDAQ : AGEN
Agenus Inc. — Financial statements
Healthcare · Biotechnology · United States
Last price 6.84 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 307.94M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Agenus Inc. (AGEN) reported revenue of 132.69M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Operating Revenue | 132.69M | 114.20M | 103.46M | 156.31M | 98.02M | 295.48M |
| Other Revenue | 184.00K | |||||
| Revenue | 132.69M | 114.20M | 103.46M | 156.31M | 98.02M | 295.67M |
| Cost of Revenue | -18.06M | 3.97M | 12.48M | 9.35M | 197.26M | 182.08M |
| Gross Profit | 150.75M | 110.22M | 90.98M | 146.97M | -99.23M | 113.59M |
| Selling, General & Admin | 38.48M | 54.39M | 71.88M | 78.74M | 81.01M | 76.36M |
| Research & Development | 76.39M | 76.39M | 143.53M | 228.33M | ||
| Operating Expenses | 114.87M | 130.78M | 215.41M | 307.07M | 81.01M | 76.36M |
| Operating Income | 35.88M | -20.56M | -124.43M | -160.10M | -180.24M | 37.23M |
| Interest Expense | -59.45M | -55.62M | -120.42M | -103.86M | -64.12M | -65.72M |
| Interest & Investment Income | 345.00K | 345.00K | 2.79M | 5.93M | 2.26M | |
| Currency Exchange Gain (Loss) | -200.00K | -200.00K | -29.00K | -100.00K | -400.00K | 1.00M |
| Other Non Operating Income (Expenses) | 2.60M | 1.68M | 1.24M | 5.00K | 2.78M | 651.00K |
| EBT Excluding Unusual Items | -20.81M | -74.35M | -240.84M | -258.12M | -239.72M | -26.84M |
| Gain (Loss) on Sale of Investments | -25.17M | -26.34M | ||||
| Gain (Loss) on Sale of Assets | 137.80M | 97.42M | 185.00K | 132.00K | 16.30M | 3.40M |
| Asset Writedown | -200.00K | -200.00K | -900.00K | -6.11M | ||
| Other Unusual Items | 318.00K | 387.00K | 9.29M | 556.00K | -1.12M | -5.28M |
| Pretax Income | 91.94M | -3.08M | -232.27M | -257.44M | -230.66M | -28.72M |
| Earnings From Continuing Operations | 91.94M | -3.08M | -232.27M | -257.44M | -230.66M | -28.72M |
| Minority Interest in Earnings | 74.00K | 3.20M | 5.06M | 11.68M | 10.58M | 4.80M |
| Net Income | 92.01M | 115.00K | -227.21M | -245.76M | -220.07M | -23.93M |
| Preferred Dividends & Other Adjustments | 217.00K | 216.00K | 215.00K | 213.00K | 212.00K | 211.00K |
| Net Income to Common | 91.80M | -101.00K | -227.43M | -245.97M | -220.29M | -24.14M |
| Shares Outstanding (Basic) | 36.41M | 29.73M | 21.47M | 17.89M | 14.09M | 11.45M |
| Shares Outstanding (Diluted) | 36.64M | 29.73M | 21.47M | 17.89M | 14.09M | 11.45M |
| EPS (Basic) | 2.52 | -0.00 | -10.59 | -13.75 | -15.64 | -2.11 |
| EPS (Diluted) | 2.51 | -0.00 | -10.59 | -13.75 | -15.64 | -2.11 |
| Free Cash Flow | -98.50M | -77.20M | -158.89M | -234.16M | -228.44M | -23.67M |
| Free Cash Flow Per Share | -2.69 | -2.60 | -7.40 | -13.09 | -16.22 | -2.07 |
| Gross Margin | 113.61% | 96.52% | 87.93% | 94.02% | -101.24% | 38.42% |
| Operating Margin | 27.04% | -18.00% | -120.26% | -102.43% | -183.88% | 12.59% |
| Profit Margin | 69.18% | -0.09% | -219.81% | -157.36% | -224.73% | -8.16% |
| Free Cash Flow Margin | -74.23% | -67.60% | -153.57% | -149.80% | -233.04% | -8.00% |
| EBITDA | 40.61M | -10.56M | -111.09M | -146.52M | -173.30M | 44.02M |
| EBITDA Margin | 30.60% | -9.25% | -107.37% | -93.73% | -176.79% | 14.89% |
| D&A For EBITDA | 4.73M | 10.00M | 13.34M | 13.59M | 6.95M | 6.79M |
| EBIT | 35.88M | -20.56M | -124.43M | -160.10M | -180.24M | 37.23M |
| EBIT Margin | 27.04% | -18.00% | -120.26% | -102.43% | -183.88% | 12.59% |
| Revenue as Reported | 132.69M | 114.20M | 103.46M | 156.31M | 98.02M | 295.67M |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 18.74M | 3.00M | 40.44M | 76.11M | 178.67M | 291.93M |
| Short-Term Investments | 14.68M | 14.99M | ||||
| Cash & Short-Term Investments | 18.74M | 3.00M | 40.44M | 76.11M | 193.36M | 306.92M |
| Receivables | 55.20M | 7.01M | 407.00K | 25.84M | 2.74M | 1.52M |
| Prepaid Expenses | 2.85M | 785.00K | 2.31M | 8.10M | 13.83M | 20.36M |
| Other Current Assets | 2.02M | 122.64M | 2.42M | 2.37M | 3.19M | 3.17M |
| Total Current Assets | 78.81M | 133.44M | 45.57M | 112.42M | 213.12M | 331.97M |
| Property, Plant & Equipment | 21.53M | 23.21M | 147.40M | 163.03M | 164.29M | 91.08M |
| Long-Term Investments | 27.38M | 25.58M | 1.01M | 3.22M | ||
| Goodwill | 24.09M | 24.09M | 24.09M | 24.72M | 25.47M | 24.88M |
| Other Intangible Assets | 2.88M | 3.04M | 3.38M | 4.41M | 6.23M | 8.49M |
| Other Long-Term Assets | 18.00M | 17.44M | 4.83M | 6.11M | 4.45M | 9.54M |
| Total Assets | 172.69M | 226.80M | 226.27M | 313.91M | 413.56M | 465.96M |
| Accounts Payable | 58.98M | 82.99M | 61.47M | 61.45M | 40.94M | 30.49M |
| Accrued Expenses | 27.52M | 34.22M | 34.96M | 45.28M | 38.26M | 42.09M |
| Current Portion of Long-Term Debt | 30.07M | 44.66M | 2.70M | 146.00K | 575.00K | 728.00K |
| Current Portion of Leases | 1.10M | 1.14M | 7.15M | 13.04M | 9.89M | 2.96M |
| Current Unearned Revenue | 31.00K | 18.00K | 12.27M | 12.43M | ||
| Other Current Liabilities | 114.15M | 160.49M | 115.09M | 135.96M | 87.02M | 68.25M |
| Total Current Liabilities | 231.82M | 323.49M | 221.40M | 255.90M | 188.95M | 156.94M |
| Long-Term Debt | 30.47M | 12.77M | 12.58M | 12.82M | ||
| Long-Term Leases | 9.54M | 10.12M | 54.67M | 67.23M | 75.60M | 42.43M |
| Long-Term Unearned Revenue | 1.14M | 1.14M | 1.14M | 1.14M | 1.14M | 11.20M |
| Other Long-Term Liabilities | 136.04M | 169.90M | 225.01M | 125.26M | 190.18M | 194.66M |
| Total Liabilities | 378.54M | 504.66M | 532.70M | 462.30M | 468.46M | 418.05M |
| Common Stock | 427.00K | 353.00K | 236.00K | 197.00K | 3.06M | 2.57M |
| Additional Paid-In Capital | 1.95B | 1.91B | 1.86B | 1.80B | 1.64B | 1.52B |
| Retained Earnings | -2.14B | -2.18B | -2.18B | -1.96B | -1.71B | -1.49B |
| Comprehensive Income & Other | -450.00K | -439.00K | -1.40M | -955.00K | 915.00K | 1.49M |
| Total Common Equity | -199.07M | -271.11M | -326.38M | -160.33M | -61.28M | 34.44M |
| Minority Interest | -6.78M | -6.75M | 19.96M | 11.95M | 6.38M | 13.47M |
| Shareholders' Equity | -205.85M | -277.86M | -306.42M | -148.38M | -54.90M | 47.91M |
| Total Liabilities & Equity | 172.69M | 226.80M | 226.27M | 313.91M | 413.56M | 465.96M |
| Total Debt | 40.71M | 55.92M | 94.98M | 93.19M | 98.65M | 58.94M |
| Net Cash (Debt) | -21.97M | -52.92M | -54.55M | -17.08M | 94.71M | 247.98M |
| Net Cash Per Share | -0.60 | -1.78 | -2.54 | -0.95 | 6.72 | 21.67 |
| Filing Date Shares Outstanding | 45.02M | 38.40M | 25.31M | 20.95M | 16.63M | 12.86M |
| Total Common Shares Outstanding | 42.62M | 35.32M | 23.63M | 19.72M | 15.28M | 12.84M |
| Working Capital | -153.01M | -190.05M | -175.83M | -143.48M | 24.17M | 175.03M |
| Book Value Per Share | -4.67 | -7.68 | -13.81 | -8.13 | -4.01 | 2.68 |
| Tangible Book Value | -226.05M | -298.24M | -353.85M | -189.47M | -92.97M | 1.08M |
| Tangible Book Value Per Share | -5.30 | -8.44 | -14.97 | -9.61 | -6.09 | 0.08 |
| Land | 10.06M | 12.29M | 12.29M | 12.29M | 17.97M | |
| Buildings | 5.84M | 5.84M | 5.65M | 5.63M | ||
| Machinery | 20.42M | 69.50M | 70.72M | 64.79M | 31.97M | |
| Construction In Progress | 56.00K | 784.00K | 1.51M | 66.46M | 16.84M | |
| Leasehold Improvements | 23.61M | 94.86M | 95.64M | 28.76M | 28.66M |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | 92.01M | 115.00K | -227.21M | -245.76M | -220.07M | -23.93M |
| Depreciation & Amortization | 4.73M | 10.00M | 13.34M | 13.59M | 6.95M | 6.79M |
| Loss (Gain) From Sale of Assets | -141.37M | -99.99M | 1.15M | -1.41M | -16.20M | -3.30M |
| Asset Writedown & Restructuring Costs | -153.00K | -153.00K | -1.98M | -556.00K | 6.11M | |
| Loss (Gain) From Sale of Investments | 24.25M | 26.12M | 1.54M | 2.13M | ||
| Stock-Based Compensation | 11.41M | 13.77M | 17.39M | 22.87M | 18.34M | 19.58M |
| Other Operating Activities | -55.01M | -54.39M | 4.85M | -25.82M | 5.42M | 20.75M |
| Change in Accounts Receivable | -14.39M | -1.73M | 25.34M | -23.46M | 122.00K | -394.00K |
| Change in Accounts Payable | -13.19M | 23.50M | 2.01M | 21.37M | 6.49M | 10.82M |
| Change in Unearned Revenue | 1.00K | 20.00K | -12.25M | -10.37M | -21.83M | |
| Change in Other Net Operating Assets | -6.78M | 5.56M | 5.23M | 25.10M | 27.84M | 1.66M |
| Operating Cash Flow | -98.50M | -77.19M | -158.31M | -224.20M | -175.37M | 10.14M |
| Capital Expenditures | -6.00K | -576.00K | -9.95M | -53.06M | -33.81M | |
| Sale of Property, Plant & Equipment | 64.26M | 359.00K | 24.00K | 3.36M | 22.00M | 5.66M |
| Cash Acquisitions | -2.92M | |||||
| Investment in Securities | 813.00K | 841.00K | 579.00K | 9.99M | 371.00K | -14.99M |
| Investing Cash Flow | 70.08M | 1.19M | 27.00K | 3.40M | -33.61M | -43.15M |
| Long-Term Debt Issued | 12.50M | 20.00M | ||||
| Long-Term Debt Repaid | -10.15M | -10.48M | -8.93M | -490.00K | -1.32M | |
| Net Debt Issued (Repaid) | -2.14M | 2.35M | 9.52M | -8.93M | -490.00K | -1.32M |
| Issuance of Common Stock | 39.91M | 36.30M | 33.67M | 133.96M | 100.11M | 206.78M |
| Repurchase of Common Stock | -54.00K | -87.00K | -4.57M | -3.79M | -1.65M | |
| Other Financing Activities | -1.97M | -1.97M | 79.65M | -606.00K | 21.45M | |
| Financing Cash Flow | 35.75M | 36.59M | 122.84M | 119.87M | 95.83M | 225.26M |
| Foreign Exchange Rate Adjustments | -37.00K | 47.00K | -260.00K | -628.00K | -104.00K | -164.00K |
| Net Cash Flow | 7.28M | -39.36M | -35.71M | -101.56M | -113.26M | 192.09M |
| Free Cash Flow | -98.50M | -77.20M | -158.89M | -234.16M | -228.44M | -23.67M |
| Free Cash Flow Margin | -74.23% | -67.60% | -153.57% | -149.80% | -233.04% | -8.00% |
| Free Cash Flow Per Share | -2.69 | -2.60 | -7.40 | -13.09 | -16.22 | -2.07 |
| Levered Free Cash Flow | -74.79M | -83.00M | -112.92M | -90.79M | -149.99M | -9.50M |
| Unlevered Free Cash Flow | -37.63M | -48.24M | -37.66M | -25.88M | -109.91M | 31.58M |
| Cash Interest Paid | 1.23M | 1.18M | 2.28M | 3.17M | 1.14M | 1.15M |
| Change in Working Capital | -34.36M | 27.33M | 32.60M | 10.76M | 24.08M | -9.74M |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 307.94M | 106.79M | 64.28M | 315.84M | 731.55M | 827.00M |
| Enterprise Value | 329.91M | 142.74M | 118.89M | 320.19M | 601.04M | 613.76M |
| Last Close Price | 6.84 | 3.14 | 2.74 | 16.56 | 47.10 | 63.20 |
| Forward PE | 23.84 | 30.59 | 30.59 | 30.59 | 30.59 | |
| PS Ratio | 2.32 | 0.94 | 0.62 | 2.02 | 7.46 | 2.80 |
| PB Ratio | -0.38 | -0.21 | -2.13 | -13.32 | 17.26 | |
| P/TBV Ratio | 768.58 | |||||
| P/OCF Ratio | 81.52 | |||||
| EV/Sales Ratio | 2.49 | 1.25 | 1.15 | 2.05 | 6.13 | 2.08 |
| EV/EBITDA Ratio | 8.12 | 13.94 | ||||
| EV/EBIT Ratio | 9.19 | 16.49 | ||||
| Debt / Equity Ratio | -0.20 | -0.20 | -0.31 | -0.63 | -1.80 | 1.23 |
| Debt / EBITDA Ratio | 0.81 | 1.09 | ||||
| Net Debt / Equity Ratio | -0.11 | -0.19 | -0.18 | -0.12 | 1.73 | -5.18 |
| Net Debt / EBITDA Ratio | 0.54 | -5.01 | -0.49 | -0.12 | 0.55 | -5.63 |
| Net Debt / FCF Ratio | -0.22 | -0.69 | -0.34 | -0.07 | 0.41 | 10.48 |
| Asset Turnover | 0.74 | 0.50 | 0.38 | 0.43 | 0.22 | 0.87 |
| Quick Ratio | 0.32 | 0.03 | 0.18 | 0.40 | 1.04 | 1.97 |
| Current Ratio | 0.34 | 0.41 | 0.21 | 0.44 | 1.13 | 2.12 |
| Return on Assets (ROA) | 12.53% | -5.67% | -28.79% | -27.51% | -25.62% | 6.84% |
| Return on Capital Employed (ROCE) | -60.70% | 21.30% | -2,555.00% | -276.00% | -80.20% | 12.00% |
| Earnings Yield | 36.63% | 0.11% | -353.49% | -77.81% | -30.08% | -2.89% |
| FCF Yield | -31.99% | -72.30% | -247.20% | -74.14% | -31.23% | -2.86% |
| Buyback Yield / Dilution | -51.00% | -38.47% | -20.00% | -27.02% | -23.07% | -32.70% |